FCM
ITCI
Farallon Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,055,000
| Closed | -$403M | – | 160 |
|
|
2025
Q1 | $403M | Buy |
+3,055,000
| New | +$403M | 2% | 18 |
|
|
2024
Q2 | – | Sell |
-231,000
| Closed | -$16M | – | 186 |
|
|
2024
Q1 | $16M | Buy |
+231,000
| New | +$16M | 0.07% | 78 |
|
|
2019
Q1 | – | Sell |
-250,000
| Closed | -$2.85M | – | 104 |
|
|
2018
Q4 | $2.85M | Hold |
250,000
| – | – | 0.02% | 90 |
|
|
2018
Q3 | $5.43M | Buy |
+250,000
| New | +$5.43M | 0.03% | 87 |
|